Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®

NCT06857708 is registered in ClinicalTrials.gov with Benjamin T. Miller as lead sponsor.

NCT NCT06857708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06857708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
Lead sponsor
Benjamin T. Miller
Phase
Not applicable
Overall status
Recruiting
Start date
March 5, 2025
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing fascitis, necrotizing soft tissue infection